A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumors from the inside out. "Bacteria spores enter the ...
This partnership builds on a Non-Disclosure Agreement established in March 2025 and officially launches research activities focused on Bioxytran’s lead drug candidate, PHM23. The study will evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results